This is evidenced by an increased index of expansion following anti-TNF treatment for active rheumatoid arthritis [106] or an increase in TH1/2/17 cytokines produced in IBD and psoriasis [107]. The gene discussed is TNF; the disease is inflammatory bowel disease.